Nanomedicine News

RSS

BIND Reports Positive Results from BIND-014 Polymeric Nanoparticle Phase 2 Study in NSCLC

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today presented positive results from its ongoing Phase 2 study of BIND-014 in non-small cell lung cancer (NSCLC), demonstrating it has met the primary objective in the once every three weeks (Q3W) arm as measured by overall response rate (ORR).

20 Nov 2014

Biodegradable Gelatin Embedded with Nano-Sized Silicate Discs Aids in Blood Coagulation

Internal bleeding is a leading cause of death on the battlefield, but a new, injectable material developed by team of researchers from Texas A&M University and the Massachusetts Institute of Technology could buy wounded soldiers the time they need to survive by preventing blood loss from serious internal injuries.

20 Nov 2014

Novel Nanoparticles Can Simultaneously Perform MRI and Fluorescent Imaging in Living Animals

MIT chemists have developed new nanoparticles that can simultaneously perform magnetic resonance imaging (MRI) and fluorescent imaging in living animals. Such particles could help scientists to track specific molecules produced in the body, monitor a tumor’s environment, or determine whether drugs have successfully reached their targets.

20 Nov 2014

Foreign Policy Magazine Honors Koch Institute Faculty Member as One of 100 Leading Global Thinkers

Koch Institute faculty member Sangeeta Bhatia has been selected as one of Foreign Policy magazine’s 100 Leading Global Thinkers of 2014 for her work in developing inexpensive and noninvasive diagnostics for the early detection of colon cancer.

20 Nov 2014

Biochemists Create Large Nanoscale Protein Container

UCLA biochemists have created the largest-ever protein that self-assembles into a molecular “cage.” The research could lead to synthetic vaccines that protect people from the flu, HIV and other diseases.

19 Nov 2014

Prototype of Skin Patch That Delivers Vaccine through Nanofibers Presented at Collegiate Inventors Competition

From the first-ever full, variable color 3D printing technology to a skin patch that can deliver a vaccine through nanofibers without a needle - the prototypes and research presented at the Collegiate Inventors Competition were nothing short of genius. After an intense and exciting deliberation between expert judges, the 2014 undergraduate and graduate winners have been selected.

18 Nov 2014

Joint Venture on Multifunctional Nanoparticles for Magnetic Hyperthermia and Indirect Radiation Therapy

NPL is one of the founders of a European project, launched last week, which aims to improve the knowledge of combined cancer therapies by pairing experienced scientists and young researchers from nanophysics, chemical science and medicine.

18 Nov 2014

Tekmira Licenses Lipid Nanoparticle Delivery Technology for Dicerna's PH1 Development Program

Tekmira Pharmaceuticals Corporation a leading developer of RNA interference (RNAi) therapeutics, today announces a licensing and collaboration agreement with Dicerna Pharmaceuticals, Inc. Tekmira has licensed its proprietary lipid nanoparticle (LNP) delivery technology for exclusive use in Dicerna's primary hyperoxaluria type 1 (PH1) development program.

18 Nov 2014

Researchers Chemically Disguise RNAi Drugs to Enter Cells

Small pieces of synthetic RNA trigger a RNA interference (RNAi) response that holds great therapeutic potential to treat a number of diseases, especially cancer and pandemic viruses. The problem is delivery -- it is extremely difficult to get RNAi drugs inside the cells in which they are needed. To overcome this hurdle, researchers at University of California, San Diego School of Medicine have developed a way to chemically disguise RNAi drugs so that they are able to enter cells. Once inside, cellular machinery converts these disguised drug precursors -- called siRNNs -- into active RNAi drugs. The technique will publish Nov. 17 in Nature Biotechnology.

18 Nov 2014

Genetic-Based NanoFlare Technology Can Detect Live Cancer Cells in the Bloodstream

Metastasis is bad news for cancer patients. Northwestern University scientists now have demonstrated a simple but powerful tool that can detect live cancer cells in the bloodstream, potentially long before the cells could settle somewhere in the body and form a dangerous tumor.

18 Nov 2014

Nanomedicine News

BIND Reports Positive Results from BIND-014 Polymeric Nanoparticle Phase 2 Study in NSCLC

Biodegradable Gelatin Embedded with Nano-Sized Silicate Discs Aids in Blood Coagulation

Novel Nanoparticles Can Simultaneously Perform MRI and Fluorescent Imaging in Living Animals

Foreign Policy Magazine Honors Koch Institute Faculty Member as One of 100 Leading Global Thinkers

Biochemists Create Large Nanoscale Protein Container

Prototype of Skin Patch That Delivers Vaccine through Nanofibers Presented at Collegiate Inventors Competition

Joint Venture on Multifunctional Nanoparticles for Magnetic Hyperthermia and Indirect Radiation Therapy

Tekmira Licenses Lipid Nanoparticle Delivery Technology for Dicerna's PH1 Development Program

Researchers Chemically Disguise RNAi Drugs to Enter Cells

Genetic-Based NanoFlare Technology Can Detect Live Cancer Cells in the Bloodstream

Green Synthesis of Silver Nanoparticles Using Pomegranate Peel Extract

Breakthrough Nano Material Uses Sunlight to Tackle Pollution and Produce Energy

Building a Quantum Model with Nanoscale Carbon Molecules

Thermo Fisher Scientific Introduces the Vulcan™ Automated Lab to Transform Semiconductor Analysis

Nanotechnology Could Improve Odds in Treating Aggressive Breast Cancers

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting

Why is 316L Stainless Steel Important for Production?